{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:08:43Z","timestamp":1761217723396},"reference-count":36,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":337,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health","award":["Grant UL1TR000003."],"award-info":[{"award-number":["Grant UL1TR000003."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1002\/pds.3717","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T08:39:01Z","timestamp":1411979941000},"page":"1147-1153","source":"Crossref","is-referenced-by-count":17,"title":["Digoxin use and the risk for colorectal cancer"],"prefix":"10.1002","volume":"23","author":[{"given":"Ben","family":"Boursi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology; University of Pennsylvania; Philadelphia PA USA"},{"name":"Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania; Philadelphia PA USA"},{"name":"Department of Biostatistics and Epidemiology; University of Pennsylvania; Philadelphia PA USA"},{"name":"Perelman School of Medicine; University of Pennsylvania; Philadelphia PA USA"},{"name":"The Integrated Cancer Prevention Center; Tel Aviv Sourasky Medical Center; Tel Aviv Israel. Tel Aviv University; Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Haynes","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania; Philadelphia PA USA"},{"name":"Department of Biostatistics and Epidemiology; University of Pennsylvania; Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronac","family":"Mamtani","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania; Philadelphia PA USA"},{"name":"Department of Biostatistics and Epidemiology; University of Pennsylvania; Philadelphia PA USA"},{"name":"Division of Hematology\/Oncology; University of Pennsylvania; Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology; University of Pennsylvania; Philadelphia PA USA"},{"name":"Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania; Philadelphia PA USA"},{"name":"Department of Biostatistics and Epidemiology; University of Pennsylvania; Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,29]]},"reference":[{"key":"10.1002\/pds.3717-BIB0001|pds3717-cit-0001","doi-asserted-by":"crossref","first-page":"e23082","DOI":"10.4161\/onci.23082","article-title":"Trial watch - Cardiac glycosides and cancer therapy","volume":"2","author":"Menger","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1002\/pds.3717-BIB0002|pds3717-cit-0002","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.3390\/ijms14047273","article-title":"Digoxin downregulates NDRG1 and VEGF through the inhibition of HIF-1\u03b1 under hypoxic conditions in human lung adenocarcinoma A549 cells","volume":"14","author":"Wei","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1002\/pds.3717-BIB0003|pds3717-cit-0003","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/onc.2011.365","article-title":"HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"issue":"40","key":"10.1002\/pds.3717-BIB0004|pds3717-cit-0004","doi-asserted-by":"crossref","first-page":"E2707","DOI":"10.1073\/pnas.1214019109","article-title":"Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells","volume":"109","author":"Schitoa","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"50","key":"10.1002\/pds.3717-BIB0005|pds3717-cit-0005","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1073\/pnas.0809763105","article-title":"Digoxin and other cardiac glycosides inhibit HIF-1 alpha synthesis and block tumor growth","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1002\/pds.3717-BIB0006|pds3717-cit-0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cam4.189","article-title":"The effects of nonspecific HIF1a inhibitors on development of castrate resistance and metastases in prostate cancer","volume":"3","author":"Ranasinghe","year":"2014","journal-title":"Cancer Medicine"},{"issue":"16","key":"10.1002\/pds.3717-BIB0007|pds3717-cit-0007","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1158\/0008-5472.CAN-09-0891","article-title":"Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"issue":"10","key":"10.1002\/pds.3717-BIB0008|pds3717-cit-0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075905","article-title":"Ouabain, a cardiac glycoside, inhibits the Fanconi anemia\/BRCA pathway activated by DNA interstrand cross-linking agents","volume":"8","author":"Wha Jun","year":"2013","journal-title":"PLoS One"},{"key":"10.1002\/pds.3717-BIB0009|pds3717-cit-0009","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.biocel.2012.06.028","article-title":"Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways","volume":"44","author":"Wang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1002\/pds.3717-BIB0010|pds3717-cit-0010","doi-asserted-by":"crossref","DOI":"10.1002\/mc.22147","article-title":"Src mediates extracellular signal-regulated kinase 1\/2 activation and autophagic cell death induced by cardiac glycosides in human non-small cell lung cancer cell lines","author":"Wang","year":"2014","journal-title":"Mol Carcinog"},{"issue":"143","key":"10.1002\/pds.3717-BIB0011|pds3717-cit-0011","doi-asserted-by":"crossref","first-page":"143ra99","DOI":"10.1126\/scitranslmed.3003807","article-title":"Cardiac glycosides exert anticancer effects by inducing immunogenic cell death","volume":"4","author":"Menger","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1002\/pds.3717-BIB0012|pds3717-cit-0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(04)00292-3","article-title":"Up-regulation of Na(+),K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer","volume":"563","author":"Sakai","year":"2004","journal-title":"FEBS Lett"},{"issue":"37","key":"10.1002\/pds.3717-BIB0013|pds3717-cit-0013","doi-asserted-by":"crossref","first-page":"32394","DOI":"10.1074\/jbc.M110.207597","article-title":"Na\/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells","volume":"286","author":"Zhichuan","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1002\/pds.3717-BIB0014|pds3717-cit-0014","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/1078-0432.CCR-11-1389","article-title":"Molecular pathways: digoxin use and estrogen-sensitive cancers - risks and possible therapeutic implications","volume":"18","author":"Biggar","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pds.3717-BIB0015|pds3717-cit-0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ijc.26424","article-title":"Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix","volume":"131","author":"Biggar","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1002\/pds.3717-BIB0016|pds3717-cit-0016","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2205","article-title":"Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study","volume":"10","author":"Ahern","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"16","key":"10.1002\/pds.3717-BIB0017|pds3717-cit-0017","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2010.32.8146","article-title":"Digoxin Use and the Risk of Breast Cancer in Women","volume":"29","author":"Biggar","year":"2011","journal-title":"JCO"},{"key":"10.1002\/pds.3717-BIB0018|pds3717-cit-0018","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr3386","article-title":"Breast cancer in women using digoxin: tumor characteristics and relapse risk","volume":"15","author":"Biggar","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1002\/pds.3717-BIB0019|pds3717-cit-0019","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-014-2886-x","article-title":"Digoxin use and risk of invasive breast cancer: evidence from the Nurses\u2019 Health Study and meta-analysis","volume":"144","author":"Ahern","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/pds.3717-BIB0020|pds3717-cit-0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8274.CD-10-0020","article-title":"A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment","volume":"1","author":"Platz","year":"2011","journal-title":"Cancer Discovery"},{"key":"10.1002\/pds.3717-BIB0021|pds3717-cit-0021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/pros.22733","article-title":"Is digoxin use for cardiovascular disease associated with risk of prostate cancer?","volume":"74","author":"Wright","year":"2014","journal-title":"Prostate"},{"key":"10.1002\/pds.3717-BIB0022|pds3717-cit-0022","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bju.12287","article-title":"A cohort study of digoxin exposure and mortality in men with prostate cancer","volume":"113","author":"Flahavan","year":"2014","journal-title":"BJU Int"},{"key":"10.1002\/pds.3717-BIB0023|pds3717-cit-0023","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/np900210m","article-title":"Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs","volume":"72","author":"Felth","year":"2009","journal-title":"J Nat Prod"},{"issue":"32","key":"10.1002\/pds.3717-BIB0024|pds3717-cit-0024","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2012.42.7732","article-title":"Estrogen plus progestin and colorectal cancer incidence and mortality","volume":"30","author":"Simon","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6732","key":"10.1002\/pds.3717-BIB0025|pds3717-cit-0025","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"BMJ"},{"key":"10.1002\/pds.3717-BIB0026|pds3717-cit-0026","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14236\/jhi.v12i3.124","article-title":"Feasibility study and methodology to create a quality-evaluated database of primary care data","volume":"12","author":"Bourke","year":"2004","journal-title":"Inform Prim Care"},{"key":"10.1002\/pds.3717-BIB0027|pds3717-cit-0027","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"10.1002\/pds.3717-BIB0028|pds3717-cit-0028","first-page":"36","article-title":"The general practice research database: quality of morbidity data","volume":"87","author":"Hollowell","year":"1997","journal-title":"Popul Trends"},{"key":"10.1002\/pds.3717-BIB0029|pds3717-cit-0029","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1001\/jama.285.14.1850","article-title":"Use of statins and risk of fractures","volume":"285","author":"Van-Staa","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/pds.3717-BIB0030|pds3717-cit-0030","first-page":"730","article-title":"Cancer incidence in The Health Improvement Network","volume":"18","author":"Haynes","year":"2009","journal-title":"PDS"},{"key":"10.1002\/pds.3717-BIB0031|pds3717-cit-0031","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the general practice research database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1002\/pds.3717-BIB0032|pds3717-cit-0032","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001648-200101000-00015","article-title":"Reduced risk of CRC among long-term users of aspirin and nonaspirin NSAIDS","volume":"1","author":"Garcia-Rodriguez","year":"2001","journal-title":"Epidemiology"},{"key":"10.1002\/pds.3717-BIB0033|pds3717-cit-0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2307\/2530744","article-title":"Biased selection of controls for case-control analysis of cohort studies","volume":"40","author":"Lubin","year":"1984","journal-title":"Biometrics"},{"issue":"9","key":"10.1002\/pds.3717-BIB0034|pds3717-cit-0034","doi-asserted-by":"crossref","first-page":"e74616","DOI":"10.1371\/journal.pone.0074616","article-title":"Increased Risk of Colorectal Cancer in Type 2 Diabetes Is Independent of Diet Quality","volume":"8","author":"Jarvandi","year":"2013","journal-title":"Plos One"},{"issue":"12","key":"10.1002\/pds.3717-BIB0035|pds3717-cit-0035","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jama.298.12.1412","article-title":"Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease","volume":"298","author":"Chan","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/pds.3717-BIB0036|pds3717-cit-0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(80)90363-0","article-title":"The problem of \u201cprotopathic bias\u201d in case control studies","volume":"68","author":"Horwitz","year":"1980","journal-title":"Am J Med"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3717","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,5]],"date-time":"2018-08-05T23:59:53Z","timestamp":1533513593000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pds.3717"}},"subtitle":["DIGOXIN USE AND THE RISK FOR COLORECTAL CANCER"],"short-title":[],"issued":{"date-parts":[[2014,9,29]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3717","relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,29]]}}}